Patient's Hot Flashes Highlight Treatment Challenges in Breast Cancer
The article discusses the severe hot flushes experienced by women undergoing anti-oestrogen therapy for breast cancer, highlighting the lack of effective treatments for this common side effect. It introduces a promising new drug, elinzanetant, which has shown in trials to significantly reduce hot flushes and improve quality of life, though it is not yet approved. The piece emphasizes the ongoing challenge of managing side effects to improve treatment adherence and outcomes for breast cancer patients.